PMC:7253482 / 1799-2250
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
67 | 382-387 | Gene | denotes | spike | Gene:43740568 |
76 | 69-79 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
77 | 213-219 | Species | denotes | humans | Tax:9606 |
79 | 94-103 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T10 | 392-400 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T10 | 69-77 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 69-73 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 213-219 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T11 | 369-374 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 392-400 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 322-331 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T272 | 6-14 | NN | denotes | syndrome |
T273 | 15-26 | NN | denotes | coronavirus |
T274 | 27-28 | -LRB- | denotes | ( |
T275 | 28-36 | NN | denotes | MERS-CoV |
T276 | 36-37 | -RRB- | denotes | ) |
T277 | 38-40 | IN | denotes | in |
T278 | 41-46 | CD | denotes | 20123 |
T279 | 46-47 | -COMMA- | denotes | , |
T280 | 48-51 | CC | denotes | and |
T281 | 52-56 | RBS | denotes | most |
T282 | 57-65 | RB | denotes | recently |
T283 | 66-68 | IN | denotes | of |
T284 | 69-80 | NN | denotes | SARS-CoV-24 |
T285 | 82-87 | VBN | denotes | Given |
T286 | 88-93 | PRP-DOLLAR- | denotes | their |
T287 | 94-103 | NN | denotes | mortality |
T288 | 104-109 | NNS | denotes | rates |
T289 | 109-110 | -COMMA- | denotes | , |
T290 | 111-114 | DT | denotes | the |
T291 | 115-122 | JJ | denotes | current |
T292 | 123-127 | NN | denotes | lack |
T293 | 128-130 | IN | denotes | of |
T294 | 131-139 | VBN | denotes | targeted |
T295 | 140-150 | NNS | denotes | treatments |
T296 | 151-154 | CC | denotes | and |
T297 | 155-163 | JJ | denotes | licensed |
T298 | 164-172 | NNS | denotes | vaccines |
T299 | 172-173 | -COMMA- | denotes | , |
T300 | 174-177 | CC | denotes | and |
T301 | 178-183 | PRP-DOLLAR- | denotes | their |
T302 | 184-192 | NN | denotes | capacity |
T303 | 193-195 | TO | denotes | to |
T304 | 196-204 | VB | denotes | transmit |
T305 | 205-212 | IN | denotes | between |
T306 | 213-219 | NNS | denotes | humans |
T307 | 220-223 | CC | denotes | and |
T308 | 224-230 | IN | denotes | across |
T309 | 231-238 | NNS | denotes | species |
T310 | 239-250 | NN | denotes | barriers5,6 |
T311 | 250-251 | -COMMA- | denotes | , |
T312 | 252-257 | EX | denotes | there |
T313 | 258-260 | VBZ | denotes | is |
T314 | 261-263 | DT | denotes | an |
T315 | 264-270 | JJ | denotes | urgent |
T316 | 271-275 | NN | denotes | need |
T317 | 276-279 | IN | denotes | for |
T318 | 280-289 | JJ | denotes | effective |
T319 | 290-305 | NNS | denotes | countermeasures |
T320 | 306-308 | TO | denotes | to |
T321 | 309-315 | VB | denotes | combat |
T322 | 316-321 | DT | denotes | these |
T323 | 322-331 | NNS | denotes | pathogens |
T324 | 333-340 | VBG | denotes | Ongoing |
T325 | 341-348 | NN | denotes | vaccine |
T326 | 349-360 | NN | denotes | development |
T327 | 361-368 | NNS | denotes | efforts |
T328 | 369-374 | NN | denotes | focus |
T329 | 375-377 | IN | denotes | on |
T330 | 378-381 | DT | denotes | the |
T331 | 382-387 | NN | denotes | spike |
T332 | 388-389 | -LRB- | denotes | ( |
T333 | 389-390 | NN | denotes | S |
T334 | 390-391 | -RRB- | denotes | ) |
T335 | 392-400 | NNS | denotes | proteins |
T336 | 401-405 | WDT | denotes | that |
T337 | 406-414 | VBP | denotes | protrude |
T338 | 415-419 | IN | denotes | from |
T339 | 420-423 | DT | denotes | the |
T340 | 424-429 | JJ | denotes | viral |
T341 | 430-438 | NN | denotes | envelope |
T342 | 439-442 | CC | denotes | and |
R267 | T273 | T272 | arg1Of | coronavirus,syndrome |
R268 | T273 | T274 | arg1Of | coronavirus,( |
R269 | T275 | T274 | arg2Of | MERS-CoV,( |
R270 | T276 | T274 | arg3Of | ),( |
R271 | T273 | T277 | arg1Of | coronavirus,in |
R272 | T278 | T277 | arg2Of | 20123,in |
R273 | T280 | T279 | arg1Of | and,"," |
R274 | T277 | T280 | arg1Of | in,and |
R275 | T283 | T280 | arg2Of | of,and |
R276 | T282 | T281 | arg1Of | recently,most |
R277 | T283 | T282 | arg1Of | of,recently |
R278 | T273 | T283 | arg1Of | coronavirus,of |
R279 | T284 | T283 | arg2Of | SARS-CoV-24,of |
R280 | T313 | T285 | arg1Of | is,Given |
R281 | T300 | T285 | arg2Of | and,Given |
R282 | T288 | T286 | arg1Of | rates,their |
R283 | T288 | T287 | arg1Of | rates,mortality |
R284 | T288 | T289 | arg1Of | rates,"," |
R285 | T292 | T289 | arg2Of | lack,"," |
R286 | T292 | T290 | arg1Of | lack,the |
R287 | T292 | T291 | arg1Of | lack,current |
R288 | T292 | T293 | arg1Of | lack,of |
R289 | T296 | T293 | arg2Of | and,of |
R290 | T295 | T294 | arg2Of | treatments,targeted |
R291 | T295 | T296 | arg1Of | treatments,and |
R292 | T298 | T296 | arg2Of | vaccines,and |
R293 | T298 | T297 | arg1Of | vaccines,licensed |
R294 | T300 | T299 | arg1Of | and,"," |
R295 | T289 | T300 | arg1Of | ",",and |
R296 | T302 | T300 | arg2Of | capacity,and |
R297 | T302 | T301 | arg1Of | capacity,their |
R298 | T304 | T303 | arg1Of | transmit,to |
R299 | T302 | T303 | modOf | capacity,to |
R300 | T304 | T305 | arg1Of | transmit,between |
R301 | T306 | T305 | arg2Of | humans,between |
R302 | T285 | T307 | arg1Of | Given,and |
R303 | T308 | T307 | arg2Of | across,and |
R304 | T313 | T308 | arg1Of | is,across |
R305 | T310 | T308 | arg2Of | "barriers5,6",across |
R306 | T310 | T309 | arg1Of | "barriers5,6",species |
R307 | T313 | T311 | arg1Of | is,"," |
R308 | T312 | T313 | arg1Of | there,is |
R309 | T316 | T313 | arg2Of | need,is |
R310 | T316 | T314 | arg1Of | need,an |
R311 | T316 | T315 | arg1Of | need,urgent |
R312 | T316 | T317 | arg1Of | need,for |
R313 | T319 | T317 | arg2Of | countermeasures,for |
R314 | T321 | T317 | arg3Of | combat,for |
R315 | T319 | T318 | arg1Of | countermeasures,effective |
R316 | T321 | T320 | arg1Of | combat,to |
R317 | T319 | T321 | arg1Of | countermeasures,combat |
R318 | T323 | T321 | arg2Of | pathogens,combat |
R319 | T323 | T322 | arg1Of | pathogens,these |
R320 | T328 | T324 | arg1Of | focus,Ongoing |
R321 | T328 | T325 | arg1Of | focus,vaccine |
R322 | T328 | T326 | arg1Of | focus,development |
R323 | T328 | T327 | arg1Of | focus,efforts |
R324 | T328 | T329 | arg1Of | focus,on |
R325 | T335 | T329 | arg2Of | proteins,on |
R326 | T335 | T330 | arg1Of | proteins,the |
R327 | T335 | T331 | arg1Of | proteins,spike |
R328 | T335 | T332 | arg1Of | proteins,( |
R329 | T333 | T332 | arg2Of | S,( |
R330 | T334 | T332 | arg3Of | ),( |
R331 | T335 | T336 | arg1Of | proteins,that |
R332 | T335 | T337 | arg1Of | proteins,protrude |
R333 | T337 | T338 | arg1Of | protrude,from |
R334 | T341 | T338 | arg2Of | envelope,from |
R335 | T341 | T339 | arg1Of | envelope,the |
R336 | T341 | T340 | arg1Of | envelope,viral |
R337 | T337 | T342 | arg1Of | protrude,and |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T10 | 392-400 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 392-400 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T16 | 28-36 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
T17 | 69-77 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T18 | 69-73 | Species | denotes | SARS | NCBItxid:694009 |
T19 | 213-219 | Species | denotes | humans | NCBItxid:9605 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 82-332 | Sentence | denotes | Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T10 | 69-77 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 69-73 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
76 | 69-79 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
79 | 94-103 | Disease | denotes | mortality | MESH:D003643 |
77 | 213-219 | Species | denotes | humans | Tax:9606 |
67 | 382-387 | Gene | denotes | spike | Gene:43740568 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T714 | 388-400 | Protein | denotes | (S) proteins | https://www.uniprot.org/uniprot/Q9UIP0|https://www.uniprot.org/uniprot/Q9UIN9|https://www.uniprot.org/uniprot/Q9UIN8|https://www.uniprot.org/uniprot/Q9UIN7|https://www.uniprot.org/uniprot/Q9UIN6|https://www.uniprot.org/uniprot/Q9UBH8|https://www.uniprot.org/uniprot/Q9NRH8|https://www.uniprot.org/uniprot/Q9NRH7|https://www.uniprot.org/uniprot/Q9NRH6|https://www.uniprot.org/uniprot/Q9NRH5|https://www.uniprot.org/uniprot/Q9NRH4|https://www.uniprot.org/uniprot/Q9NPG5|https://www.uniprot.org/uniprot/Q9NPE0|https://www.uniprot.org/uniprot/Q9NP52|https://www.uniprot.org/uniprot/Q95IF9|https://www.uniprot.org/uniprot/Q8N5P3|https://www.uniprot.org/uniprot/Q8IZU6|https://www.uniprot.org/uniprot/Q8IZU5|https://www.uniprot.org/uniprot/Q8IZU4|https://www.uniprot.org/uniprot/Q86Z04|https://www.uniprot.org/uniprot/Q7YR44|https://www.uniprot.org/uniprot/Q7LA71|https://www.uniprot.org/uniprot/Q7LA70|https://www.uniprot.org/uniprot/Q5STD2|https://www.uniprot.org/uniprot/Q5SQ85|https://www.uniprot.org/uniprot/Q1XI16|https://www.uniprot.org/uniprot/Q1XI12|https://www.uniprot.org/uniprot/Q15517|https://www.uniprot.org/uniprot/O43509|https://www.uniprot.org/uniprot/O19084|https://www.uniprot.org/uniprot/B0UYZ7|https://www.uniprot.org/uniprot/B0S7V2|https://www.uniprot.org/uniprot/A5A6L9 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 82-332 | Sentence | denotes | Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens. |